Related Experiment Video
Updated: Jan 1, 2026

Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide
Published on: May 12, 2023
Lixisenatide enhances mitochondrial biogenesis and function through regulating the CREB/PGC-1α pathway
1Department of Cardiology, The No.4 Hospital of Jinan, 250031, Shandong, China.
Lixisenatide, a type 2 diabetes drug, enhances mitochondrial biogenesis in endothelial cells by activating the CREB-PGC-1α pathway. This improves mitochondrial function and cellular respiration, offering potential benefits for cardiovascular health.
Area of Science:
- Cardiovascular Biology
- Mitochondrial Medicine
- Endothelial Cell Function
Background:
- Mitochondrial dysfunction is linked to cardiovascular diseases.
- Lixisenatide is a type 2 diabetes medication with limited known effects on endothelial mitochondria.
Purpose of the Study:
- To investigate the impact of lixisenatide on mitochondrial biogenesis and function in human umbilical vein endothelial cells (HUVECs).
Main Methods:
- Assessed expression of key mitochondrial biogenesis genes (PGC-1α, NRF1, TFAM).
- Measured mitochondrial DNA content, mass, enzyme activity, respiration, and ATP production.
- Investigated the role of CREB signaling pathway activation.
Main Results:
- Lixisenatide increased PGC-1α, NRF1, and TFAM expression in HUVECs.
- Promoted mitochondrial biogenesis, evidenced by increased mtDNA/nDNA ratio and mitochondrial mass.
- Enhanced mitochondrial respiration and ATP generation, linked to CREB phosphorylation.
Conclusions:
- Lixisenatide promotes endothelial mitochondrial biogenesis via the CREB-PGC-1α signaling pathway.
- Suggests a potential therapeutic mechanism for lixisenatide in cardiovascular health beyond diabetes management.
More Related Videos
09:50Application of Chronic Stimulation to Study Contractile Activity-induced Rat Skeletal Muscle Phenotypic Adaptations
Published on: January 25, 2018
12:32High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
Related Concept Videos
Lipid Catabolism
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Regulation of Metabolism
Mitochondrial Precursor Proteins
Most of the mitochondrial...
Regulation of Nuclear Protein Sorting
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...